Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Chiesa

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Experimental Cell Research|August 5, 2015
High-density lipoprotein deficiency in genetically modified mice deeply affects skin morphology: A structural and ultrastructural studyFrancesca Arnaboldi, Marco Busnelli, Laura Cornaghi, et al.
Pharmacological Research|December 30, 2018
Topiramate protects apoE-deficient mice from kidney damage without affecting plasma lipidsStefano Manzini, Marco Busnelli, Cinzia Parolini, et al.
British Journal of Pharmacology|April 14, 2011
Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDLMarta Marchesi, Cinzia Parolini, Silvia Caligari, et al.
Thrombosis and Haemostasis|October 25, 2021
Rupatadine Treatment Is Associated with Atherosclerosis Worsening and Altered T Lymphocyte RecruitmentMarco Busnelli, Stefano Manzini, Alice Colombo, et al.
The Canadian Journal of Cardiology|September 10, 2019
Infusions of Large Synthetic HDL Containing Trimeric apoA-I Stabilize Atherosclerotic Plaques in Hypercholesterolemic RabbitsCinzia Parolini, Maria Pia Adorni, Marco Busnelli, et al.
Thrombosis and Haemostasis|October 25, 2012
Acute ApoA-I Milano administration induces plaque regression and stabilisation in the long termChiara Giannarelli, Giovanni Cimmino, Borja Ibanez, et al.
Biochimica Et Biophysica Acta|July 20, 2010
The intracellular quality control system down-regulates the secretion of amyloidogenic apolipoprotein A-I variants: a possible impact on the natural history of the diseaseMarta Marchesi, Cinzia Parolini, Caterina Valetti, et al.
British Journal of Pharmacology|October 18, 2019
Fenretinide treatment accelerates atherosclerosis development in apoE-deficient mice in spite of beneficial metabolic effectsMarco Busnelli, Stefano Manzini, Fabrizia Bonacina, et al.
Scientific Reports|March 15, 2017
Liver-specific deletion of the Plpp3 gene alters plasma lipid composition and worsens atherosclerosis in apoE<sup>-/-</sup> miceMarco Busnelli, Stefano Manzini, Mika Hilvo, et al.
Molecular Nutrition & Food Research|June 25, 2020
Fat-Shaped Microbiota Affects Lipid Metabolism, Liver Steatosis, and Intestinal Homeostasis in Mice Fed a Low-Protein DietMarco Busnelli, Stefano Manzini, Amin Jablaoui, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Experimental Cell Research|August 5, 2015
High-density lipoprotein deficiency in genetically modified mice deeply affects skin morphology: A structural and ultrastructural studyFrancesca Arnaboldi, Marco Busnelli, Laura Cornaghi, et al.
Pharmacological Research|December 30, 2018
Topiramate protects apoE-deficient mice from kidney damage without affecting plasma lipidsStefano Manzini, Marco Busnelli, Cinzia Parolini, et al.
British Journal of Pharmacology|April 14, 2011
Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDLMarta Marchesi, Cinzia Parolini, Silvia Caligari, et al.
Thrombosis and Haemostasis|October 25, 2021
Rupatadine Treatment Is Associated with Atherosclerosis Worsening and Altered T Lymphocyte RecruitmentMarco Busnelli, Stefano Manzini, Alice Colombo, et al.
The Canadian Journal of Cardiology|September 10, 2019
Infusions of Large Synthetic HDL Containing Trimeric apoA-I Stabilize Atherosclerotic Plaques in Hypercholesterolemic RabbitsCinzia Parolini, Maria Pia Adorni, Marco Busnelli, et al.
Thrombosis and Haemostasis|October 25, 2012
Acute ApoA-I Milano administration induces plaque regression and stabilisation in the long termChiara Giannarelli, Giovanni Cimmino, Borja Ibanez, et al.
Biochimica Et Biophysica Acta|July 20, 2010
The intracellular quality control system down-regulates the secretion of amyloidogenic apolipoprotein A-I variants: a possible impact on the natural history of the diseaseMarta Marchesi, Cinzia Parolini, Caterina Valetti, et al.
British Journal of Pharmacology|October 18, 2019
Fenretinide treatment accelerates atherosclerosis development in apoE-deficient mice in spite of beneficial metabolic effectsMarco Busnelli, Stefano Manzini, Fabrizia Bonacina, et al.
Scientific Reports|March 15, 2017
Liver-specific deletion of the Plpp3 gene alters plasma lipid composition and worsens atherosclerosis in apoE<sup>-/-</sup> miceMarco Busnelli, Stefano Manzini, Mika Hilvo, et al.
Molecular Nutrition & Food Research|June 25, 2020
Fat-Shaped Microbiota Affects Lipid Metabolism, Liver Steatosis, and Intestinal Homeostasis in Mice Fed a Low-Protein DietMarco Busnelli, Stefano Manzini, Amin Jablaoui, et al.
Pageof 7